Default company panoramic image
Logo

CombImmune, Inc.

CombImmune is focusing on the development of intelligently designed cancer regimens and diagnostics in a combinatorial approach.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Palo Alto, CA, USA
  • Currency USD
  • Founded September 2012
  • Employees 3
  • Website combimmune.com

Company Summary

CombImmune is a medical oncology and diagnostic company which intends to design and market novel immunotherapeutic and diagnostic tools related to the oncology and hematology marketplace. CombImmune's mission is to utilize prognostic and predictive biomarkers which inform us about the immune dysfunction to the tumor infiltration in combination with therapeutics which restore immune function and destruction of the tumor.

Team

  • Default avatar
    Russell Kent Pachynski, MD
    Chief Scientific Officer

  • Default avatar
    Holbrook Kohrt, MD, PhD
    Chief Medical Officer

    http://med.stanford.edu/profiles/Holbrook_Kohrt/

  • Default avatar
    Jason Yonehiro
    Chief Executive Officer

Advisors

  • Default avatar
    Glen Sato
    Lawyer
    Unconfirmed